Mergers & Acquisitions - Sorrento Therapeutics

Filter

Current filters:

Sorrento Therapeutics

Popular Filters

226 to 250 of 842 results

Spectrum Pharma adds to hematology and oncology portfolio with acquisition

18-07-2013

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) says that it has entered into an agreement to…

BiotechnologyMarqiboMenadioneMergers & AcquisitionsSpectrum PharmaceuticalsTalon Therapeutics

New regenerative company Cesca created through merger

17-07-2013

USA-based ThermoGenesis (Nasdaq: KOOL), a leading supplier of enabling technologies for the processing…

BiotechnologyCesca TherapeuticsMergers & AcquisitionsThermoGenesisTotipotentRx

Ocera Thera and Tranzyme complete merger

16-07-2013

US clinical-stage biopharma firm Ocera Therapeutics and Tranzyme (Nasdaq: TZYM) have completed their…

BiotechnologyMergers & AcquisitionsNephrology and HepatologyOcera TherapeuticsOCR-002Tranzyme

Ipsen makes acquisition and signs R&D deal with Harvard

15-07-2013

French drugmaker Ipsen (Euronext: IPN) has acquired UK life sciences company Syntaxin for an upfront…

EuropeIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSyntaxin

Mitsubishi Tanabe to acquire 60% of Canada's Medicago in $172 million deal

12-07-2013

Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has reached agreement to acquire 60% of Canada's…

MedicagoMergers & AcquisitionsMitsubishi TanabePharmaceuticalVaccines

Italy's Chiesi gains rights to uniQure's Glybera

12-07-2013

Netherlands-based venture capital backed human gene therapy firm uniQure has signed collaboration agreements…

BiotechnologyChiesi FarmaceuticiGlyberaLicensingMergers & AcquisitionsPharmaceuticaluniQure

Serodus to acquire Phlogo to expand cardiovascular portfolio

12-07-2013

Norwegian biopharma company Serodus (Oslo Axess: SER) says that, following approval by an extraordinary…

BiotechnologyCardio-vascularMergers & AcquisitionsPhlogoSER130SER140Serodus

Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma

10-07-2013

Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

Fresenius gets US FDA warning over Indian plant; divests biotech unit

09-07-2013

Germany-based Fresenius Kabi has received a warning letter from the US Food and Drug Administration in…

Fresenius BiotechFresenius KabiMergers & AcquisitionsNeoPharmPharmaceuticalRegulationRemovab

Nile Therapeutics will merge with Capricor to become new company focused on heart disease

08-07-2013

USA-based Nile Therapeutics (OTCQB: NLTX) has today (July 8) announced a merger with privately-held Californian…

BiotechnologyCapricorCapricor TherapeuticscenderitideMergers & AcquisitionsNile Therapeutics

XOMA transfers perindopril franchise rights to Symplmed

08-07-2013

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has transferred US development and commercialization…

Cardio-vascularLicensingMergers & AcquisitionsperindoprilPharmaceuticalServierSymplmedXOMA Corp

South Africa's Adcock Ingram confirms takeover bid from CFR Pharma

04-07-2013

In what was described as a "cautionary" statement, South Africa's largest drugmaker Adcock Ingram (AIP:…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Mayne Pharma makes second US acquisition, this time generic drugmaker Libertas

03-07-2013

In a second move into the US market in less than a year, Australia's Mayne Pharma (ASX: MYX) says it…

GenericsLibertas PharmaMayne PharmaMergers & Acquisitions

Pharmstandard may sell its non-Rx business for $2.5 billion; AbbVie Russian plans

02-07-2013

Pharmstandard, Russia's largest drug producer, is considering selling its production of non-prescription…

AbbVieEuropeMergers & AcquisitionsPharmaceuticalPharmstandardProductionR-Pharma

Onyx Pharma rejects Amgen's unsolicited $120 per share takeover offer

01-07-2013

Following a day of speculation and rumor on Friday, US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX)…

AmgenBayerBiotechnologyCelgeneMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizerRoche

MorphoSys and Celgene in deal to advance MOR202 for multiple myeloma

27-06-2013

German biotech firm MorphoSys (FSE: MOR) and USA-based Celgene (Nasdaq: CELG), the world's largest independent…

BiotechnologyCelgeneEuropeLicensingMergers & AcquisitionsMOR202MorphoSysOncology

Pfizer details final spinoff of Zoetis

20-06-2013

US pharma behemoth Pfizer (NYSE: PFE) has announced the final exchange ratio of 0.9898 for the animal…

FinancialMergers & AcquisitionsPharmaceutical

Royalty pulls plug on Elan buy (for now?); analysts' view on what comes next

19-06-2013

In the ongoing hostile takeover saga, US private equity firm Royalty Pharma has withdrawn its request…

ElanMergers & AcquisitionsPharmaceuticalRoyalty Pharma

226 to 250 of 842 results

Back to top